Literature DB >> 10633467

Medical and surgical aspects of parathyroidectomy.

M Fukagawa1, Y Tominaga, M Kitaoka, T Kakuta, K Kurokawa.   

Abstract

A more logical approach to the management of the chronic dialysis patient with parathyroid hyperplasia has become possible thanks to recent progress in cellular and molecular analysis of surgically removed parathyroid glands and accumulation of clinical experience. When one or more parathyroid glands progress to the stage of nodular hyperplasia, it is usually difficult to control PTH secretion even by calcitriol pulse therapy. For such patients, we have developed two new therapeutic approaches, i.e., selective percutaneous ethanol injection therapy (PEIT) and direct calcitriol injection therapy, in combination with medical therapy. For optimal selection of therapeutic modalities it is indispensable to evaluate the degree and stage of parathyroid hyperplasia. For successful management, prevention of nodular hyperplasia is the most important strategy.

Entities:  

Mesh:

Year:  1999        PMID: 10633467     DOI: 10.1046/j.1523-1755.1999.07309.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

Review 1.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism.

Authors:  Cláudia Ribeiro; Maria Goretti Moreira Guimarães Penido; Milena Maria Moreira Guimarães; Marcelo de Sousa Tavares; Bruno das Neves Souza; Anderson Ferreira Leite; Leonardo Martins Caldeira de Deus; Lucas José de Campos Machado
Journal:  World J Nephrol       Date:  2016-09-06

3.  Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

Authors:  Yuko Oyama; Junichiro James Kazama; Kentaro Omori; Noboru Higuchi; Shigemi Kameda; Suguru Yamamoto; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

4.  Assessment of parathyroid glands in hemodialysis patients by using color Doppler sonography.

Authors:  Umit Aksoy Ozcan; Ilay Oktay
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

5.  Catch-up growth with normal parathyroid hormone levels in chronic renal failure.

Authors:  Simon Waller; Sarah Ledermann; Richard Trompeter; William van't Hoff; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

6.  Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.

Authors:  Takatoshi Kakuta; Masafumi Fukagawa; Masafumi Kitaoka; Fumihiko Koiwa; Noritaka Onoda; Yasuhiro Tominaga; Tadao Akizawa; Kiyoshi Kurokawa
Journal:  NDT Plus       Date:  2008-08

7.  Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial.

Authors:  Reika Tanaka; Takatoshi Kakuta; Fumihiko Koiwa; Masafumi Fukagawa; Akira Saito
Journal:  NDT Plus       Date:  2008-08

8.  The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism.

Authors:  Motoko Tanaka; Hirotaka Komaba; Kazuko Itoh; Kazunori Matsushita; Kazutaka Matshushita; Yasuhiro Hamada; Hideki Fujii; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.